PETALING JAYA: Pharmaceutical firm CCM Duopharma Biotech Bhd
has been appointed the reseller of human insulin medication by Biocon Sdn Bhd, the local subsidiary of Biocon Ltd, a biopharmaceutical company based in Bengaluru, India.
Biocon was awarded the contract to manufacture the insulin medication under the Health Ministry’s off-take programme. The contract, commencing Dec 2 last year, will last till Dec 1, 2019 with a total contract value of RM300mil.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
